Moreover, previous studies indicated that LUCAT1 could be a potential prognostic biomarker for patients with several cancers (Yoon et al., 2018; Yu et al., 2018; Zhou et al., 2019; Huan et al., 2020; Yang and Xia, 2020), including renal cancer (Wang et al., 2018; Zheng et al., 2018; Wang Y et al., 2019). The gene discussed is LUCAT1; the disease is cancer.